Advertisement

Inpharma Weekly

, Volume 1556, Issue 1, pp 5–5 | Cite as

Bosentan potentially cost effective in PAH

Clinical study
  • 3 Downloads

Keywords

Conventional Therapy Bosentan Calcium Channel Antagonist Risk Sharing Average Life Expectancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2006

Personalised recommendations